Physician

Kenneth M Carnes, M.D.

According to 2025 Medicare claims, Kenneth Carnes, M.D. (NPI: 1003845363) practices neurology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RALEIGH NEUROLOGY ASSOCIATES, P. A. (NPI: 1215954003; TIN: 562002729) and primary practice location at 27607-5253.

Carnes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 563 traditional Medicare patients, billed 33,890 HCPCS/CPT codes, and received $851,347 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,619 prescription claims across 723 beneficiaries totaling $868,919 in drug costs, led by Ingrezza (Valbenazine Tosylate). Open Payments data shows 308 records totaling $162,907. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $116,915 to $851,347. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	744	2,659	$116,915
2016	773	8,513	$186,405
2017	798	15,957	$355,921
2018	782	18,544	$387,468
2019	798	15,930	$432,747
2020	703	16,618	$414,257
2021	716	7,460	$192,020
2022	791	6,658	$218,210
2023	657	29,114	$806,718
2024	563	33,890	$851,347

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	544	4,628	$834,091
2016	564	4,988	$665,355
2017	590	4,709	$719,177
2018	613	4,686	$741,566
2019	676	5,099	$709,025
2020	686	5,390	$708,497
2021	726	5,496	$737,858
2022	789	5,431	$677,746
2023	753	5,630	$868,918
2024	723	5,619	$868,919

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	112	112	$95
70551	Mri scan of brain without contrast	30	30	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	337	541	$55
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	50	102	$43
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	113	133	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	12	360	$97,353
Plegridy Pen	Peginterferon Beta-1a	12	336	$97,032
Austedo	Deutetrabenazine	13	390	$63,887
Aimovig Autoinjector	Erenumab-Aooe	66	2,554	$61,944
Wellbutrin Xl	Bupropion Hcl	24	720	$54,706

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	292	$5,794	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	16	$157,112	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kenneth M. Carnes, M.D.?

Tedicare shows public-source Medicare data for Kenneth M. Carnes, M.D. (NPI 1003845363), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kenneth M. Carnes, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kenneth M. Carnes, M.D.?

Kenneth M. Carnes, M.D. is linked to RALEIGH NEUROLOGY ASSOCIATES, P. A. (billing NPI 1215954003) in the available physician profile data.

Does Kenneth M. Carnes, M.D. have Open Payments data?

Kenneth M. Carnes, M.D. has 308 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.